Inflammation contributes to colon cancer
Janssen-Cilag announced today that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of moderate to severe plaque psoriasis from the European Committee for Medical Products for Human Use (CHMP). This positive opinion takes patients living with the physical and mental burdens of psoriasis a step closer
Full Post: Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis
Researchers led by Drs. Lillian Maggio-Price and Brian Iritani at The University of Washington found that mice that lack the immune inhibitory molecule Smad3 are acutely sensitive to both bacterially-induced inflammation and cancer.
They report these findings in the January 2009 issue of The American Journal of Pathology.
Bacteria contribute to the development of certain cancers, in some measure, by stimulating chronic inflammation. Absence of a molecule that inhibits inflammation, Smad3, may therefore increase susceptibility to colon cancer.
To examine whether Smad3 signaling contributes to development of colon cancer, Maggio-Price et al examined mice deficient in Smad3 that lack of adaptive immune responses. They found that these mice are acutely sensitive to bacterially-induced inflammation and cancer due to both deficient T regulatory cell function and increased expression of proinflammatory cytokines. Through increased expression of both pro-oncogenic and anti-apoptotic proteins, epithelial cells in colonic tissues underwent both enhanced proliferation and survival.
“That the inflammatory response to microorganisms is a key event in these results reveals important ‘tumor-suppressive’ functions for Smad3 in T effector cells, T regulatory cells, and intestinal epithelial cells, all of which may normally limit the development of colon cancer in response to bacterial inflammation,” explains the groups led by Dr. Maggio-Price and Dr. Iritani.
A colon cancer cell isn’t a lost cause. Vitamin D can tame the rogue cell by adjusting everything from its gene expression to its cytoskeleton. In the Nov. 17 issue of the Journal of Cell Biology, Ordonez-Morán et al. show that one pathway governs the vitamin’s diverse effects. The results help clarify the actions
Full Post: Study helps clarify role of vitamin D in cancer therapy
Rheumatoid arthritis is a painful, inflammatory type of arthritis that occurs when the body’s immune system attacks itself. A new paper, published in this week’s issue of PLoS Biology, reports a breakthrough in the understanding of how autoimmune responses can be controlled, offering a promising new strategy for therapy development for rheumatoid arthritis. Normally, immune
Full Post: Breakthrough in rheumatoid arthritis research
A research team from the University of California, San Diego School of Medicine has identified a protein produced by cancerous lung epithelial cells that enhances metastasis by stimulating the activity of inflammatory cells. Their findings, to be published in the January 1 issue of the journal Nature, explain how advanced cancer cells usurp components of
Full Post: Lung cancer cells activate inflammation to induce metastasis
With up to half of a person’s body mass consisting of skeletal muscle, chronic inflammation of those muscles - which include those found in the limbs - can result in significant physical impairment. According to University of Illinois kinesiology and community health professor Kimberly Huey, past research has demonstrated that the antioxidant properties of Vitamin
Full Post: Vitamin E supplementation may reduce inflammation in the brain
Cincinnati scientists have identified a new biomarker that could help predict a person’s risk of developing colon cancer and how aggressive it may become. The University of Cincinnati (UC) team has identified “hotspots”-areas of deleted genetic data-that play a critical role in regulating gene expression and influence colon cancer progression. Researchers speculate that these hotspots
Full Post: Potential new biomarker for colon cancer